Proof Diagnostics is helping communities take control of their health with CRISPR-based COVID-19 molecular testing.
Investors 2
| Date | Name | Website |
| - | F-Prime Ca... | fprimecapi... |
| - | Madrona Ve... | madrona.co... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 19.12.2022 | Point of Care Molecular Diagnostics Market is Valued at USD ... | Point of Care Molecular Diagnostics Market Point of Care Molecular Diagnostics Market Industry Anal... | einpresswi... |
| 26.05.2022 | Global Point of Care Diagnostics Market is Expected to Repre... | Point of Care Diagnostics Market by Platform (Immunoassays, Lateral Flow Assays, Molecular Diagnosti... | einpresswi... |
| 26.05.2022 | Global Point of Care Diagnostics Market is Expected to Repre... | Newark, NJ, May 26, 2022 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, The global... | globenewsw... |
| 01.08.2018 | A medical diagnostics startup that wants to use CRISPR techn... | Mammoth Biosciences The science team behind Mammoth Biosciences Advertisement Mammoth Biosciences... | businessin... |